Relationship between initial electroencephalographic characteristics and seizure outcomes in children with non-lesional West syndrome

被引:4
|
作者
Lee, Yun-Jin [1 ,2 ]
Yeon, Gyu Min [3 ]
Kim, Young Mi [4 ]
Nam, Sang Ook [1 ,2 ]
机构
[1] Pusan Natl Univ, Childrens Hosp, Sch Med, Dept Pediat, Yangsan 626770, Gyeongsangnam D, South Korea
[2] Pusan Natl Univ, Yangsan Hosp, Res Inst Convergence Biomed Sci & Technol, Yangsan 626770, Gyeongsangnam D, South Korea
[3] Kosin Univ, Gospel Hosp, Dept Pediat, Pusan, South Korea
[4] Pusan Natl Univ Hosp, Dept Pediat, Pusan, South Korea
关键词
West syndrome; EEG; Seizures; Prognosis; INFANTILE SPASMS; ADRENOCORTICOTROPIC HORMONE; THERAPY; INFANCY; ONSET; BRAIN; AGE;
D O I
10.1016/j.eplepsyres.2014.11.019
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: To characterize the initial interictal electroencephalography (EEG) activities associated with seizure outcomes in children with non-lesional West syndrome (WS), and their worth in the prediction of seizure-free (SF) vs no seizure-free (No-SF) outcomes. Methods: We retrospectively reviewed the initial scalp EEGs for at least a 40-min duration, and the medical records of 66 children who were diagnosed as WS with normal MRI, and who were followed-up with for 4.5 +/- 2.1 years. We assessed the following clinical and EEG findings: onset of seizures, development, underlying etiologies, initial interictal EEGs, and seizure evolution. These variables were compared between two groups: SF vs No-SF groups. Results: In total, 36 (54.5%) children had SF outcomes and 30(45.5%) had No-SF outcomes during long-term follow-up (4.4 +/- 2.3 vs 4.6 +/- 2.0 years, p = 0.7644). The mean age at seizure onset was similar in the SF and No-SF groups (6.0 +/- 3.0 vs 6.9 +/- 3.2 months, p = 0.2443). Delayed development before the onset of spasms was similarly observed in both groups (13.9% vs 13.3%). Initial EEG findings significantly differed with typical hypsarrhythmia (41.7% vs 73.3%, p = 0.0098), multiple independent spike foci (MISF) (55.6% vs 83.3%, p = 0.0158), frontal-dominant MISF (0.0% vs 40.0%, p <0.0001), and frontal-dominant generalized epileptiform discharges (EDs) (0.0% vs 16.7%, p = 0.0108) being involved more infrequently in the SF group than in the No-SF group, respectively. Patients in the SF group showed no frontal-dominant MISF or frontal-dominant generalized EDs, and a more often normal to borderline sleep-spindle (83.3% vs 40.0%, p = 0.0002) than the No-SF group. Conclusion: Patients with SF outcomes more frequently showed the posterior-dominant generalized EDs and normal to borderline sleep-spindle, and the No-SF group more often had typical hypsarrhythmia, frontal-dominant MISF, frontal-dominant generalized EDs, and no normal sleep-spindle. Initial interictal EEG findings may predict seizure outcomes in patients with non-lesional WS. (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:49 / 54
页数:6
相关论文
共 27 条
  • [21] Tuberculosis Outcomes in Papua, Indonesia: The Relationship with Different Body Mass Index Characteristics between Papuan and Non-Papuan Ethnic Groups
    Kenangalem, Enny
    Waramori, Govert
    Pontororing, Gysje J.
    Sandjaja
    Tjitra, Emiliana
    Maguire, Graeme
    Kelly, Paul M.
    Anstey, Nicholas M.
    Ralph, Anna P.
    PLOS ONE, 2013, 8 (09):
  • [22] The longitudinal relationship between patient-reported outcomes and clinical characteristics among patients with focal segmental glomerulosclerosis in the Nephrotic Syndrome Study Network
    Troost, Jonathan P.
    Waldo, Anne
    Carlozzi, Noelle E.
    Murphy, Shannon
    Modersitzki, Frank
    Trachtman, Howard
    Nachman, Patrick H.
    Reidy, Kimberly J.
    Selewski, David T.
    Herreshoff, Emily G.
    Srivastava, Tarak
    Gibson, Keisha L.
    Derebail, Vimal K.
    Lin, Jen Jar
    Hingorani, Sangeeta
    Fornoni, Alessia
    Fervenza, Fernando C.
    Sambandam, Kamalanathan
    Athavale, Ambarish M.
    Kopp, Jeffrey B.
    Reich, Heather N.
    Adler, Sharon G.
    Greenbaum, Larry A.
    Dell, Katherine M.
    Appel, Gerald
    Wang, Chia-shi
    Sedor, John
    Kaskel, Frederick J.
    Lafayette, Richard A.
    Atkinson, Meredith A.
    Lieske, John C.
    Sethna, Christine B.
    Kretzler, Matthias
    Hladunewich, Michelle A.
    Lemley, Kevin, V
    Brown, Elizabeth
    Meyers, Kevin E.
    Gadegbeku, Crystal A.
    Holzman, Lawrence B.
    Jefferson, Jonathan Ashley
    Tuttle, Katherine R.
    Singer, Pamela
    Hogan, Marie C.
    Cattran, Daniel C.
    Barisoni, Laura
    Gipson, Debbie S.
    CLINICAL KIDNEY JOURNAL, 2020, 13 (04) : 597 - 606
  • [23] RELATIONSHIP BETWEEN PROTEINURIA AND DECREASE OF ESTIMATED GLOMERULAR FILTRATION RATE IN LONG TERM OUTCOMES OF CHILDREN WITH SHIGATOXIN-ASSOCIATED HEMOLYTIC UREMIC SYNDROME
    Hashimoto, Junya
    Hamada, Riku
    Yamamoto, Kazuna
    Hada, Ichiro
    Mikami, Naoaki
    Kubota, Wataru
    Terano, Chikako
    Harada, Ryoko
    Ishikura, Kenji
    Hataya, Hiroshi
    Honda, Masataka
    PEDIATRIC NEPHROLOGY, 2015, 30 (09) : 1647 - 1647
  • [24] Relationship between skin bacterial colonization and the occurrence of allergen-specific and non-allergen-specific antibodies in sera of children with atopic eczema/dermatitis syndrome
    Szakos, E
    Lakos, G
    Aleksza, M
    Hunyadi, J
    Farkas, M
    Sólyom, E
    Sipka, S
    ACTA DERMATO-VENEREOLOGICA, 2004, 84 (01) : 32 - 36
  • [25] Relationship between high sensitivity troponin I and clinical outcomes in non-acute coronary syndrome (non-ACS) acute heart failure patients - a one-year follow-up study
    Kumar, Abhishek
    Muneer, Kader
    Qureshi, Naeem
    INDIAN HEART JOURNAL, 2024, 76 (02) : 139 - 145
  • [26] RELATIONSHIP BETWEEN DEGREE OF CORONARY VASCULAR BED INVOLVEMENT AND CHARACTERISTICS OF STENTING WITH SHORT-TERM AND LONG-TERM OUTCOMES IN PATIENTS WITH ACUTE CORONARY SYNDROME (DATA OF THE RECORD-3 REGISTRY)
    Erlikh, A. D.
    KARDIOLOGIYA, 2018, 58 (05) : 5 - 12
  • [27] What is the relationship between F-18-fluorodeoxy-glucose positron emission tomography (FDG-PET) characteristics and outcomes in continuous hyperfractionated accelerated radiotherapy (CHART) for non-small cell lung cancer (NSCLC)?
    Rulach, R.
    Fullerton, R.
    Han, S.
    Hendry, F.
    Colville, D.
    Jones, R.
    LUNG CANCER, 2017, 103 : S3 - S3